Sign in to view content

Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients With Wet AMD, DME, and BRVO

Suber S. Huang, MD, MBA, FASRS

Video
Published 2021

Related

Real World Experience of Brolucizumab for Persistent Macular Fluid in Neovascular Age-Related Macular Degeneration After Prior Anti-VEGF Treatments
Rehan M. Hussain, MD
Annual Meeting Talks
2021
Subretinal Delivery of RGX-314 for Neovascular AMD: End of Study Phase I/IIa Results
Lejla Vajzovic, MD, FASRS
Annual Meeting Talks
2021
Surgical Case Conference Zofia Michalewska
Zofia Anna Nawrocka (vel Michalewska), MD, PhD
Annual Meeting Talks
2019

Category: Retinal Vascular Disease

See more